11. Myasthenia gravis Clinical trials / Disease details
Clinical trials : 332 / Drugs : 234 - (DrugBank : 81) / Drug target genes : 45 - Drug target pathways : 127
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01828294 (ClinicalTrials.gov) | October 2011 | 1/11/2011 | Subcutaneous Ig Maintenance Therapy for Myasthenia Gravis | Subcutaneous Ig Maintenance Therapy for Myasthenia Gravis | Myasthenia Gravis | Drug: Subcutaneous immunoglobulins | St. Louis University | CSL Behring | Terminated | 18 Years | 80 Years | All | 4 | Phase 1 | United States |